Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease

Clinical trial NCT04679883 · UNKNOWN

Trial details

NCT number: NCT04679883
Sponsor: GL Pharm Tech Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Syndromes

Start date: 2021-04-01
Primary completion: 2022-01-30
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.